NEXT

National Law Journal

E-Cigarette Advocates Say FDA's New Rules Are Unlawful

National and state trade associations representing the electronic cigarette industry on Monday sued the U.S. Food and Drug Administration over new regulations that the advocates contend will push innovative products out of the market.
6 minute read

The Legal Intelligencer

FDA's Imodium Warning a Likely Litigation Spark, Attorneys Say

A warning last week from federal regulators that the anti-diarrheal drug Imodium could cause serious heart problems will likely encourage plaintiffs to test claims in the courts, although success is far from certain, attorneys said.
4 minute read

The Recorder

Feds Squeeze $67M from Two Pharmaceutical Companies for Cancer-Drug Claims

Genentech Inc. and OSI Pharmaceuticals LLC will pay a combined $67 million to resolve allegations that they overstated the ability of the drug Tarceva to treat certain non-small cell lung cancer patients, the U.S. Attorney's Office for the Northern District of California said Monday.
4 minute read

National Law Journal

Civil Actions

Cases recently filed in the Washington-area district courts.
3 minute read

National Law Journal

Morning Wrap: Why Merrick Garland Recuses | Staples-Office Depot Deal Abandoned

Merrick Garland lists his most important cases, and he identifies dozens of cases in which he recused for financial and other reasons. Staples and Office Depot abandon their merger plan after a Washington judge finds the deal would "substantially" hurt competition. And starting in December, the federal rules of appellate procedure will change—and that means lawyers have a new, reduced word count. This is a roundup from ALM and other publications.
3 minute read

National Law Journal

Vaping Company Sues FDA Over New Regulations

Covington & Burling, representing Nicopure Labs LLC, on Tuesday sued the U.S. Food and Drug Administration over new vaping rules, which were published today. The company, which sells the devices and manufactures the "e-liquid" used, filed a lawsuit Tuesday in Washington claiming the agency overstepped its authority.
3 minute read

National Law Journal

Movers: A Weekly Roundup of Laterals and Promotions

By | April 11, 2016
Laterals and new arrivals in this week's column.
40 minute read

New Jersey Law Journal

NJ Justices Hear Pre-emption Arguments in Reglan Mass Tort

The New Jersey Supreme Court heard arguments April 11 over whether hundreds of failure-to-warn claims against makers of generic Reglan—which is used to treat gastroesophageal reflux disease—are pre-empted by federal law.
4 minute read

Litigation Daily

This is Why Kirkland's Hurst Gets the Big Bucks

When James Hurst moved from Winston & Strawn to Kirkland & Ellis in late 2014, he was dubbed “Biglaw's $9 Million Man” for his reportedly enormous new salary. The star life sciences litigator appears to be earning his keep. On Thursday, he and Kirkland partner Andrew Kassof co-led a trial team that delivered a blockbuster win on behalf of Abbott Laboratories.
8 minute read

National Law Journal

Biosimilars Market Is at a Critical Turning Point

Congress enabled their speedy approval in 2010, but courts and the FDA will determine how fast they move.
13 minute read

Resources

  • Leveraging Technology to Improve Employee Engagement and Client Satisfaction

    Brought to you by CARET Legal

    Download Now

  • How to Choose Your Legal Operations Software: Key Considerations and Expert Tips

    Brought to you by DiliTrust

    Download Now

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now